Survival in Early Phase Immuno-Oncology Trials: Development and Validation of a Prognostic Index.

Aaron R HansenChristina GuoYada KanjanapanBen TranAnna SpreaficoAnthony M JoshuaLisa WangAlbiruni R Abdul RazakNatasha B LeighlAaron R HansenMarcus O ButlerLillian L SiuJayesh DesaiPhilippe L Bedard

Published in: JNCI cancer spectrum (2019)

The PM-IPI is a validated prognostic score for patients treated in phase I IO trials and may aid in improving patient selection.

Keyphrases

palliative care
particulate matter
air pollution
case report
heavy metals
polycyclic aromatic hydrocarbons